High Metabolic Syndrome Severity Linked to Development of CKD

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 15, 2025.

via HealthDay

FRIDAY, Aug. 15, 2025 -- High metabolic syndrome (MetS) severity, expressed by the continuous metabolic syndrome severity score (cMetS-S), is associated with development of chronic kidney disease (CKD), according to a study recently published in Kidney Diseases.

Ladan Mehran, M.D., Ph.D., from the Shahid Beheshti University of Medical Sciences in Tehran, Iran, and colleagues examined the association between the trajectory of cMetS-S and development of CKD in a population-based study involving 4,462 participants aged 20 to 60 years free of CKD at baseline who were followed at three-year intervals. cMetS-S trajectories were examined over nine years (1999 to 2009) and the subsequent risks for incident CKD were assessed eight years later (2010 to 2018).

During the exposure period, three cMetS-S trajectory groups were identified: low, medium, and high (28.3, 50.0, and 21.7 percent, respectively). The researchers found that after adjustment for age, sex, education, smoking, physical activity, baseline estimated glomerular filtration rate, and even after further adjustment for MetS components, a high cMetS-S trajectory pattern was associated with an increased risk for CKD (hazard ratio, 1.32). Even in normoglycemic, nonobese, and nonhypertensive individuals, the associated risk remained significant. The MetS severity score was associated with CKD only in men in a sex-specific subgroup analysis.

"Physicians can monitor metabolic health changes by including the MetS score in routine lab results, allowing for improved metabolic health management through self-awareness and health behavior adjustments at no extra expense," the authors write. "Additional research is required to establish the risk thresholds for health results within the scoring framework."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-16 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords